Phase I trial of rituximab, cladribine, and temsirolimus (RCT) for initial therapy of mantle cell lymphoma.
- Citation:
- Ann Oncol vol 25 (10) 2020-4
- Year:
- 2014
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- Parents:
- 911
- Children:
- None
- Pharmas:
- Grants:
- U10CA180821, U10CA180882, U10 CA180821, U10 CA180882
- Corr. Author:
- Authors:
- D J Inwards P A Fishkin B R LaPlant M T Drake P J Kurtin D A Nikcevich D B Wender B S Lair T E Witzig
- Networks:
- Study
- NCCTG-N078D
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 1
- Keywords:
- cladribine, mantle cell lymphoma, temsirolimus